## Biochemistry of Vitamin K and Clinical Significance ### Clinical Context Obstructive jaundice impairs fat absorption due to lack of bile salts → vitamin K malabsorption → deficiency of vitamin K-dependent clotting factors (II, VII, IX, X) → coagulopathy with easy bruising and prolonged bleeding. ### Correct Statements (Options 0, 1, 3) **Option 0 — Vitamin K as a Cofactor:** - Vitamin K (in hydroquinone form) is an essential cofactor for γ-glutamyl carboxylase - Catalyzes post-translational carboxylation of glutamic acid (Glu) → γ-carboxyglutamic acid (Gla) - Gla residues bind Ca²⁺ and phospholipids, enabling membrane anchoring and biological activity - Affected factors: II (prothrombin), VII, IX, X, protein C, protein S - ✓ TRUE **Option 1 — Vitamin K and Bone Metabolism:** - Vitamin K is required for γ-carboxylation of **osteocalcin** (bone matrix protein) and **matrix Gla protein (MGP)** - Gla-containing proteins are essential for bone mineralization and vascular calcification regulation - Vitamin K deficiency → impaired osteocalcin carboxylation → reduced bone quality and increased fracture risk - ✓ TRUE **Option 3 — Warfarin Mechanism:** - Warfarin is a vitamin K antagonist that inhibits **vitamin K epoxide reductase** (VKOR) - VKOR catalyzes reduction of vitamin K epoxide → vitamin K hydroquinone (the active cofactor form) - Warfarin blocks this recycling pathway → depletion of functional vitamin K → impaired γ-carboxylation - ✓ TRUE ### Incorrect Statement (Option 2) — **CORRECT ANSWER** **Option 2 — Vitamin K Forms and Bioavailability:** | Feature | Phylloquinone (K1) | Menaquinone (K2) | |---------|-------------------|------------------| | **Source** | Plants (leafy greens, cruciferous vegetables) | Bacterial synthesis (gut flora), fermented foods | | **Absorption** | Proximal small intestine; requires bile salts and fat | Ileum and colon; some colonic synthesis | | **Bioavailability** | **High (~80%)** | **Lower than K1** (~10–20%) | | **Metabolic conversion** | **Used directly** as cofactor | **Requires metabolic conversion** to K1 or active form | | **Dietary contribution** | Major source (100–200 μg/day) | Minor source (10–100 μg/day) | **The statement is FALSE because:** - K1 and K2 are **NOT equally bioavailable** — K1 has superior bioavailability - K2 **DOES require metabolic conversion** — it is not used directly as a cofactor in the same way as K1 - K2 is converted to K1 or undergoes side-chain modification before becoming fully active ### Key Point: **Phylloquinone (K1) is the preferred dietary source and has superior bioavailability. Menaquinone (K2) from gut bacteria contributes minimally to total vitamin K status and requires metabolic processing.** ### High-Yield: **Vitamin K deficiency causes:** 1. Impaired synthesis of clotting factors II, VII, IX, X → ↑ PT/INR, normal aPTT initially 2. Impaired bone protein carboxylation → poor bone quality 3. Impaired vascular Gla protein synthesis → abnormal vascular calcification **Causes of vitamin K deficiency:** - Biliary obstruction (impaired fat absorption) - Antibiotic use (destroys gut flora) - Malabsorption syndromes (celiac, Crohn's, cystic fibrosis) - Dietary insufficiency (rare in developed countries) ### Clinical Pearl: **Vitamin K1 (phylloquinone) is the standard therapeutic form for vitamin K deficiency and warfarin reversal. Fresh frozen plasma or prothrombin complex concentrate (PCC) is used for urgent reversal in bleeding patients.** ### Mnemonic: **VKOR inhibition by Warfarin:** - **V** = Vitamin K - **O** = Oxidized (epoxide form) - **R** = Reductase (the enzyme warfarin blocks) - Result: Hydroquinone (active form) cannot be regenerated → ↓ γ-carboxylation → ↓ clotting factors
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.